Health ❯ Healthcare ❯ Medical Research ❯ Cancer Research

Breast Cancer

Slow-Cycling ER-Positive Cells Linked to Late Breast Cancer Relapse

The study points to Rac1 signaling as a drug target to clear residual disease.

Final Phase I Data Show Preventive TNBC Vaccine Is Safe and Induces Immune Responses in Most Participants

Roche’s Giredestrant Cuts Early Breast Cancer Recurrence 30% in Phase III Trial

Study Pinpoints Protein That Enables Drug-Triggered Rupture of Breast Cancer Cells

Triple Therapy Counters Endocrine Resistance in ER+ Breast Cancer in Preclinical Study

AI From Screening Mammograms Flags Short‑Term Risk of Interval Breast Cancers

Engineered Antibody From King’s College London Shows Preclinical Promise Against Hard-to-Treat Breast Cancers

Whole-Genome Sequencing Could Guide Care for 27% of Breast Cancer Patients, UK Study Finds

Genetic Risk Score Flags Future Breast Cancer Risk After DCIS or LCIS

Repurposed Drugs Clear Dormant Breast Cancer Cells in Phase II Trial

NF1-Low ER+ Breast Cancers Identified as Likely Responders to CDK4/6 Inhibitors

Everolimus Plus Carboplatin Delays Progression in Advanced Triple-Negative Breast Cancer, Phase 2 Study Shows

JNK Pathway Loss Drives Resistance to Endocrine and CDK4/6 Treatment in ER+ Breast Cancer

Protein TIM3 Identified as Key Driver of Breast Cancer Micrometastasis

Meta-Analysis Reveals Opposing Breast Cancer Risks of Hormone Replacement Therapy in Women Under 55

TM3-4 Peptides Suppress Breast Cancer Growth by Targeting VIPR2 Dimers

Camizestrant Cuts Breast Cancer Progression Risk by Over Half in Global Trial

UK Study Advocates New Breast Cancer Screening for Women with Dense Tissue

New Three-Drug Therapy Doubles Survival Time for Advanced Breast Cancer Patients